SEARCH OUR PRODUCT CATALOG

KLK2-FGFR2 Fusion FISH Probe

The KLK2-FGFR2 Fusion FISH Probe is used to confirm a fusion of the KLK2 and FGFR2 genes. The fusion of the KLK2 and FGFR2 genes has been associated with Prostate Adenocarcinoma, Prostate Adenocarcinoma, and Uveal Melanoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.

** This product is for in vitro and research use only. This product is not intended for diagnostic use.

Turnaround Time: 7-10 Business Days    Shipping Time: 1-2 Day Expedited Shipping

SKU Test Kits Buffer Dye Color Order Now
KLK2-FGFR2-20-ORGR  (Standard Design) 20 (40 μL) 200 μL
KLK2-FGFR2-20-RERE 20 (40 μL) 200 μL
KLK2-FGFR2-20-REOR 20 (40 μL) 200 μL
KLK2-FGFR2-20-REGO 20 (40 μL) 200 μL
KLK2-FGFR2-20-REGR 20 (40 μL) 200 μL
KLK2-FGFR2-20-REAQ 20 (40 μL) 200 μL
KLK2-FGFR2-20-ORRE 20 (40 μL) 200 μL
KLK2-FGFR2-20-OROR 20 (40 μL) 200 μL
KLK2-FGFR2-20-ORGO 20 (40 μL) 200 μL
KLK2-FGFR2-20-ORAQ 20 (40 μL) 200 μL
KLK2-FGFR2-20-GORE 20 (40 μL) 200 μL
KLK2-FGFR2-20-GOOR 20 (40 μL) 200 μL
KLK2-FGFR2-20-GOGO 20 (40 μL) 200 μL
KLK2-FGFR2-20-GOGR 20 (40 μL) 200 μL
KLK2-FGFR2-20-GOAQ 20 (40 μL) 200 μL
KLK2-FGFR2-20-GRRE 20 (40 μL) 200 μL
KLK2-FGFR2-20-GROR 20 (40 μL) 200 μL
KLK2-FGFR2-20-GRGO 20 (40 μL) 200 μL
KLK2-FGFR2-20-GRGR 20 (40 μL) 200 μL
KLK2-FGFR2-20-GRAQ 20 (40 μL) 200 μL
KLK2-FGFR2-20-AQRE 20 (40 μL) 200 μL
KLK2-FGFR2-20-AQOR 20 (40 μL) 200 μL
KLK2-FGFR2-20-AQGO 20 (40 μL) 200 μL
KLK2-FGFR2-20-AQGR 20 (40 μL) 200 μL
KLK2-FGFR2-20-AQAQ 20 (40 μL) 200 μL

FGFR2 Gene Summary

The protein encoded by this gene is a member of the fibroblast growth factor receptor family, where amino acid sequence is highly conserved between members and throughout evolution. FGFR family members differ from one another in their ligand affinities and tissue distribution. A full-length representative protein consists of an extracellular region, composed of three immunoglobulin-like domains, a single hydrophobic membrane-spanning segment and a cytoplasmic tyrosine kinase domain. The extracellular portion of the protein interacts with fibroblast growth factors, setting in motion a cascade of downstream signals, ultimately influencing mitogenesis and differentiation. This particular family member is a high-affinity receptor for acidic, basic and/or keratinocyte growth factor, depending on the isoform. Mutations in this gene are associated with Crouzon syndrome, Pfeiffer syndrome, Craniosynostosis, Apert syndrome, Jackson-Weiss syndrome, Beare-Stevenson cutis gyrata syndrome, Saethre-Chotzen syndrome, and syndromic craniosynostosis. Multiple alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Jan 2009]

Gene Name: Fibroblast Growth Factor Receptor 2

Chromosome: CHR10: 123237843 -123357972

Locus: 10q26.13

KLK2 Gene Summary

This gene encodes a member of the grandular kallikrein protein family. Kallikreins are a subgroup of serine proteases that are clustered on chromosome 19. Members of this family are involved in a diverse array of biological functions. The protein encoded by this gene is a highly active trypsin-like serine protease that selectively cleaves at arginine residues. This protein is primarily expressed in prostatic tissue and is responsible for cleaving pro-prostate-specific antigen into its enzymatically active form. This gene is highly expressed in prostate tumor cells and may be a prognostic maker for prostate cancer risk. Alternate splicing results in both coding and non-coding transcript variants. [provided by RefSeq, Jan 2012]

Gene Name: Kallikrein Related Peptidase 2

Chromosome: CHR19: 51376688 -51383823

Locus: 19q13.33

Gene Diseases

The KLK2 FGFR2 Fusion has been associated with the following diseases:

Disease Name
Prostate Adenocarcinoma
Prostate Adenocarcinoma
Uveal Melanoma

FISH Probe Protocols

Protocol, Procedure, or Form Name Last Modified Download

FGFR2 amplification in colorectal adenocarcinoma

FGFR2 amplification occurs in about 5% of gastric cancers, but so far has only been reported in one colorectal cancer (CRC) cell line, where the cells were found to require FGFR2 amplification for survival. This was the first report of FGFR2 amplification in a CRC biopsy obtained directly from a patient’s primary tumor. Our FGFR2 FISH probe helped confirm FGFR2 amplification in the subject.